Ageing, Longevity, Exceptional Longevity and Related Genetic and non GeneticsMarkers: Panel Statement.

Calogero Caruso; George Panotopoulos; Niki Katsiki; Dimitri P. Mikhailidis; Irene P. Tzanetakou; Claudio Franceschi; Athanase Benetos; Helen Bilianou; Genovefa Kolovou; Miriam Capri; Nir Barzilai; Ewa Sikora; Peter Avery

Ageing, Longevity, Exceptional Longevity and Related Genetic and non GeneticsMarkers: Panel Statement.

Calogero Caruso, George Panotopoulos, Niki Katsiki, Dimitri P. Mikhailidis, Irene P. Tzanetakou, Claudio Franceschi, Athanase Benetos, Helen Bilianou, Genovefa Kolovou, Miriam Capri, Nir Barzilai, Ewa Sikora, Peter Avery

Biomedicina, Neuroscienze e Diagnostica avanzata

Risultato della ricerca: Article › peer review

26 Citazioni (Scopus)

Abstract

In May 2012, a group of scientists and clinicians met in Athens (Greece) toconsider the relevance of ageing, longevity, exceptional longevity and relatedgenetic and non genetic markers. During this meeting, we firstly reviewed recent epidemiological and clinical studies on ageing, longevity and exceptionallongevity, briefly analysed the ageing theories and discussed successful andunsuccessful ageing also taking into account the evolutionary perspective.Secondly, we considered the three phenotypes based on the definition of ageing,longevity and exceptional longevity and the associated biomarkers. Third, wediscussed proposed treatments suitable to counteract or slow down ageing.Finally, this panel produced a consensus statement to highlight the importance ofageing, longevity and exceptional longevity, since this is a rapidly increasingphenotype worldwide. We acknowledge that not all experts in this field maycompletely agree with this statement.

Lingua originale	English
pagine (da-a)	659-661
Numero di pagine	3
Rivista	Current Vascular Pharmacology
Volume	dec 18
Stato di pubblicazione	Published - 2014

All Science Journal Classification (ASJC) codes

Pharmacology
Cardiology and Cardiovascular Medicine

Altri file e collegamenti

OA Link

Fingerprint Entra nei temi di ricerca di 'Ageing, Longevity, Exceptional Longevity and Related Genetic and non GeneticsMarkers: Panel Statement.'. Insieme formano una fingerprint unica.

Cita questo

Ageing, Longevity, Exceptional Longevity and Related Genetic and non GeneticsMarkers: Panel Statement. / Caruso, Calogero; Panotopoulos, George; Katsiki, Niki; Mikhailidis, Dimitri P.; Tzanetakou, Irene P.; Franceschi, Claudio; Benetos, Athanase; Bilianou, Helen; Kolovou, Genovefa; Capri, Miriam; Barzilai, Nir; Sikora, Ewa; Avery, Peter.

In: Current Vascular Pharmacology, Vol. dec 18, 2014, pag. 659-661.

Risultato della ricerca: Article › peer review

Caruso, Calogero ; Panotopoulos, George ; Katsiki, Niki ; Mikhailidis, Dimitri P. ; Tzanetakou, Irene P. ; Franceschi, Claudio ; Benetos, Athanase ; Bilianou, Helen ; Kolovou, Genovefa ; Capri, Miriam ; Barzilai, Nir ; Sikora, Ewa ; Avery, Peter. / Ageing, Longevity, Exceptional Longevity and Related Genetic and non GeneticsMarkers: Panel Statement. In: Current Vascular Pharmacology. 2014 ; Vol. dec 18. pagg. 659-661.

@article{85f44c0a4b1c43138ef5952b918cced4,

title = "Ageing, Longevity, Exceptional Longevity and Related Genetic and non GeneticsMarkers: Panel Statement.",

abstract = "In May 2012, a group of scientists and clinicians met in Athens (Greece) toconsider the relevance of ageing, longevity, exceptional longevity and relatedgenetic and non genetic markers. During this meeting, we firstly reviewed recent epidemiological and clinical studies on ageing, longevity and exceptionallongevity, briefly analysed the ageing theories and discussed successful andunsuccessful ageing also taking into account the evolutionary perspective.Secondly, we considered the three phenotypes based on the definition of ageing,longevity and exceptional longevity and the associated biomarkers. Third, wediscussed proposed treatments suitable to counteract or slow down ageing.Finally, this panel produced a consensus statement to highlight the importance ofageing, longevity and exceptional longevity, since this is a rapidly increasingphenotype worldwide. We acknowledge that not all experts in this field maycompletely agree with this statement.",

author = "Calogero Caruso and George Panotopoulos and Niki Katsiki and Mikhailidis, {Dimitri P.} and Tzanetakou, {Irene P.} and Claudio Franceschi and Athanase Benetos and Helen Bilianou and Genovefa Kolovou and Miriam Capri and Nir Barzilai and Ewa Sikora and Peter Avery",

year = "2014",

language = "English",

volume = "dec 18",

pages = "659--661",

journal = "Current Vascular Pharmacology",

issn = "1570-1611",

publisher = "Bentham Science Publishers B.V.",

}

TY - JOUR

T1 - Ageing, Longevity, Exceptional Longevity and Related Genetic and non GeneticsMarkers: Panel Statement.

AU - Caruso, Calogero

AU - Panotopoulos, George

AU - Katsiki, Niki

AU - Mikhailidis, Dimitri P.

AU - Tzanetakou, Irene P.

AU - Franceschi, Claudio

AU - Benetos, Athanase

AU - Bilianou, Helen

AU - Kolovou, Genovefa

AU - Capri, Miriam

AU - Barzilai, Nir

AU - Sikora, Ewa

AU - Avery, Peter

PY - 2014

Y1 - 2014

N2 - In May 2012, a group of scientists and clinicians met in Athens (Greece) toconsider the relevance of ageing, longevity, exceptional longevity and relatedgenetic and non genetic markers. During this meeting, we firstly reviewed recent epidemiological and clinical studies on ageing, longevity and exceptionallongevity, briefly analysed the ageing theories and discussed successful andunsuccessful ageing also taking into account the evolutionary perspective.Secondly, we considered the three phenotypes based on the definition of ageing,longevity and exceptional longevity and the associated biomarkers. Third, wediscussed proposed treatments suitable to counteract or slow down ageing.Finally, this panel produced a consensus statement to highlight the importance ofageing, longevity and exceptional longevity, since this is a rapidly increasingphenotype worldwide. We acknowledge that not all experts in this field maycompletely agree with this statement.

AB - In May 2012, a group of scientists and clinicians met in Athens (Greece) toconsider the relevance of ageing, longevity, exceptional longevity and relatedgenetic and non genetic markers. During this meeting, we firstly reviewed recent epidemiological and clinical studies on ageing, longevity and exceptionallongevity, briefly analysed the ageing theories and discussed successful andunsuccessful ageing also taking into account the evolutionary perspective.Secondly, we considered the three phenotypes based on the definition of ageing,longevity and exceptional longevity and the associated biomarkers. Third, wediscussed proposed treatments suitable to counteract or slow down ageing.Finally, this panel produced a consensus statement to highlight the importance ofageing, longevity and exceptional longevity, since this is a rapidly increasingphenotype worldwide. We acknowledge that not all experts in this field maycompletely agree with this statement.

UR - http://hdl.handle.net/10447/100651

M3 - Article

VL - dec 18

SP - 659

EP - 661

JO - Current Vascular Pharmacology

JF - Current Vascular Pharmacology

SN - 1570-1611

ER -